Lectins and lectibodies: potential promising antiviral agents

M Nabi-Afjadi, M Heydari, H Zalpoor, I Arman… - Cellular & Molecular …, 2022 - Springer
In nature, lectins are widely dispersed proteins that selectively recognize and bind to
carbohydrates and glycoconjugates via reversible bonds at specific binding sites. Many viral …

Understanding mutations in human SARS-CoV-2 spike glycoprotein: a systematic review & meta-analysis

R Kumar, Y Srivastava, P Muthuramalingam, SK Singh… - Viruses, 2023 - mdpi.com
Genetic variant (s) of concern (VoC) of SARS-CoV-2 have been emerging worldwide due to
mutations in the gene encoding spike glycoprotein. We performed comprehensive analyses …

mRNA: vaccine or gene therapy? The safety regulatory issues

H Banoun - International Journal of Molecular Sciences, 2023 - mdpi.com
COVID-19 vaccines were developed and approved rapidly in response to the urgency
created by the pandemic. No specific regulations existed at the time they were marketed …

Microalgae as an efficient vehicle for the production and targeted delivery of therapeutic glycoproteins against SARS-CoV-2 variants

J Dehghani, A Movafeghi, E Mathieu-Rivet… - Marine drugs, 2022 - mdpi.com
Severe acute respiratory syndrome–Coronavirus 2 (SARS-CoV-2) can infect various human
organs, including the respiratory, circulatory, nervous, and gastrointestinal ones. The virus is …

Chemical Compositions of Clove (Syzygium aromaticum (L.) Merr. & L.) Extracts and Their Potentials in Suppressing SARS-CoV-2 Spike Protein–ACE2 Binding …

Y Li, Z Liu, M Zeng, A El Kadiri, J Huang… - Journal of Agricultural …, 2022 - ACS Publications
COVID-19 is initiated by binding the SARS-CoV-2 spike protein to angiotensin-converting
enzyme 2 (ACE2) on host cells. Food factors capable of suppressing the binding between …

[HTML][HTML] Clinical approach to post-acute sequelae after COVID-19 infection and vaccination

N Hulscher, BC Procter, C Wynn, PA McCullough - Cureus, 2023 - ncbi.nlm.nih.gov
The spike protein of SARS-CoV-2 has been found to exhibit pathogenic characteristics and
be a possible cause of post-acute sequelae after SARS-CoV-2 infection or COVID-19 …

[HTML][HTML] SARS-CoV-2 VOCs, Mutational diversity and clinical outcome: Are they modulating drug efficacy by altered binding strength?

S Saifi, V Ravi, S Sharma, A Swaminathan… - Genomics, 2022 - Elsevier
The global COVID-19 pandemic continues due to emerging Severe Acute Respiratory
syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOC). Here, we performed …

Bioactive Compositions of Cinnamon (Cinnamomum verum J. Presl) Extracts and Their Capacities in Suppressing SARS-CoV-2 Spike Protein Binding to ACE2 …

Z Xie, Y Li, Z Liu, M Zeng, JC Moore… - Journal of Agricultural …, 2023 - ACS Publications
Cinnamon (Cinnamomum verum J. Presl) bark and its extracts are popular ingredients
added to food and supplement products. It has various health effects, including potentially …

Coronavirus disease 2019: clinics, treatment, and prevention

FR Burkert, L Lanser, R Bellmann-Weiler… - Frontiers in …, 2021 - frontiersin.org
The coronavirus disease 2019 (COVID-19) pandemic, caused by a novel severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), emerged at the end of 2019 in China …

[HTML][HTML] The emerging pandemic recent: SARS-CoV-2

Y Cha, W Jung, M Seo, M Rahmati - Life Cycle, 2023 - elifecycle.org
Abstract The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), induces coughing, vomiting, or fever. The …